Botswana TDF/FTC Oral HIV Prophylaxis Trial

NCT00448669 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1219

Enrollment

FED

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg
DRUG: Placebo Oral Tablet

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]